Progenics Pharmaceuticals
(PGNX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2006 | 03-2006 | 12-2005 | 09-2005 | 06-2005 | |
| Sales | 19,122 | 11,001 | 2,048 | 2,774 | 2,075 |
| Gross Profit | 19,122 | 11,001 | 2,048 | 2,774 | 2,075 |
| Operating Expenses | 35,356 | 15,554 | 35,812 | 14,097 | 15,175 |
| Operating Income | -16,234 | -4,553 | -33,764 | -11,323 | -13,100 |
| Other Income | 1,906 | 1,910 | 1,268 | 580 | 305 |
| Pre-tax Income | -14,328 | -2,643 | -32,496 | -10,743 | -12,795 |
| Net Income Continuous | -14,328 | -2,643 | -32,697 | -10,743 | -12,795 |
| Net Income | $-14,328 | $-2,643 | $-32,697 | $-10,743 | $-12,795 |
| EPS Basic Total Ops | -0.56 | -0.10 | -1.43 | -0.49 | -0.65 |
| EPS Basic Continuous Ops | -0.56 | -0.10 | -1.43 | -0.49 | -0.65 |
| EPS Diluted Total Ops | -0.56 | -0.10 | -1.43 | -0.49 | -0.65 |
| EPS Diluted Continuous Ops | -0.56 | -0.10 | -1.43 | -0.49 | -0.65 |
| EBITDA(a) | $-15,839 | $-4,168 | $-32,175 | $-10,527 | $-12,341 |